CVPath Pathology Study Presented at TCT
At the recent TCT 2022 conference held in Boston, MA, Dr. Aloke Finn, Primary Investigator and Dr. Yu Sato, lead investigator, discussed and presented findings related to the development of thrombi on transcatheter aortic valves leaflets identified on computed tomography (CT) scans and termed hypoattenuated leaflet thickening (HALT). Dr Sato used a registry of self-expanding transcatheter aortic valves (TAV) collected at autopsy or during explant to explore the pathogenesis of HALT. He reported that thrombi became more organized on TAVs implanted for longer durations of time, which may result in implications for the potential treatment of hypoattenuated leaflet thickening (HALT). His data emphasize the need for early detection and treatment or HALT.
You can find the full article here:
Below is the interview of Dr. Finn at TCT: (please click on the link on the screen to begin the video)